Abstract
The possibility of directing drugs selectively to their cellular targets was considered for the first time by Paul Ehrlich at the beginning of this century. It is, however, only since about twenty years that developments in biology and medicine have incited an increasing number of laboratories to try to translate this dream into reality. One of the most promising and most explored approaches is the linkage of very active but toxic pharmacological agents to carriers which will transport and target these selectively to sites of action.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.E. Wall, G.S. Abernethy and F.I. Carroll, The effects of some steroidal alkylating agents on experimental animal mammary tumour and leukemia systems, J. Med. Chem. 12: 810 (1969)
G. Gregoriadis, Targeting of drugs, Nature, 265: 407 (1977)
G. Poste, The interaction of lipid vesicles (liposomes) with cultured cells and their use as carrier for drugs and macromolecules, in “Liposomes in Biological Systems”, G. Gregoriadis and A.C. Allison, eds., John Wiley & Sons, Chichester (1980)
J. Kreuter and P. Speiser, In vitro studies of poly(methyl metacrylate) adjuvants, J. Pharm. Sci. 65: 1624 (1976)
F. Moolten, S. Zajdel and S. Cooperband, Immunotherapy of experimental animal tumors with antitumor antibodies conjugated to diphteria toxin or ricin, Ann.N.Y. Acad. Sci. 277: 690 (1976)
A. Trouet, D. Deprez De Campeneere and C. de Duve, Chemotherapy through lysosomes with a DNA-daunorubicin complex, Nature, 239: 110 (1972)
R. Baurain, D. Deprez De Campeneere and A. Trouet, Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: plasma levels in DBA2 mice, Cancer Chemother.Pharmacol. 2: 11 (1979)
M. Masquelier, R. Baurain and A. Trouet, Amino acid and dipeptide derivatives of daunorubicin: I. Synthesis, physico-chemical properties and lysosomal digestion, J. Med. Chem. 23: 1166 (1980)
E. Hurwitz, R. Levy, R. Maron, M. Wilchek, R. Arnon and M. Sela, The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities, Cancer Res. 35: 1175 (1975)
E. Hurwitz, R. Maron, R. Arnon, M. Wilchek, and M. Sela, Daunomycin-immunoglobulin conjugates, uptake and activity in vitro, Eur. J. Cancer, 44: 1213 (1978)
M. Monsigny, C. Kieda, A-C. Roche and F. Delmotte, Preparation and biological properties of a covalent antitumor drug-armcarrier (DAC conjugate), FEBS Lett. 119: 181 (1980)
A.G. Morell, G. Gregoriadis, I.H. Scheinberg, J. Hickman and G. Ashwell, The role of sialic acid in determining the survival of glycoproteins in the circulation, J. Biol. Chem., 246: 1461 (1971)
P. Pirson, R.F. Steiger and A. Trouet, Liposomes in the chemotherapy of experimental murine malaria, Ann. Trop. Med. Parasitol, 74: 383 (1980)
A. Trouet, P. Pirson, R.F. Steiger, M. Masquelier, R. Baurain and J. Gillet, Development of new derivatives of primaquine by association with lysosomotropic carriers, Bull. WHO, 59: 449 (1981)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Trouet, A., Baurain, R., Deprez-De Campeneere, D., Masquelier, M., Pirson, P. (1982). Targeting of Antitumour and Antiprotozoal Drugs by Covalent Linkage to Protein Carriers. In: Gregoriadis, G., Senior, J., Trouet, A. (eds) Targeting of Drugs. NATO Advanced Study Institutes Series, vol 47. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4241-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4241-0_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4243-4
Online ISBN: 978-1-4684-4241-0
eBook Packages: Springer Book Archive